1835667-63-4(贝福替尼)
1835667-63-4 基本信息更多
- 中文名称:贝福替尼
- 中文同义词: BEFOTERTINIB 化合物BEFOTERTINIB 贝福替尼 N-(2-((2-(二甲基氨基)乙基)(甲基)氨基)-4-甲氧基-5-((4-(1-(2,2,2-三氟乙基)-1H-吲哚-3-基)嘧啶-2-基)氨基)苯基)丙烯酰胺 化合物BEFOTERTINIB,10 MM DMSO 溶液
- 英文名称:Befotertinib
- 英文同义词: N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-(2,2,2-trifluoroethyl)-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide 2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-[1-(2,2,2-trifluoroethyl)-1H-indol-3-yl]-2-pyrimidinyl]amino]phenyl]- Befotertinib CPD0557 lung,Epidermal growth factor receptor,D0316,D 0316,ErbB-1,Inhibitor,HER1,inhibit,cancer,EGFR,kinase,tyrosine,non-small,NSCLC Befotertinib, 10 mM in DMSO Befotertinib (D-0316) N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-[1-(2,2,2-trifluoroethyl)-1H-indol-3-yl]-2-pyrimidinyl]amino]phenyl]-2-propenamide (ACI)
- CAS号:1835667-63-4
- 分子式:C29H32F3N7O2
- 分子量:567.61
- EINECS号:
- Mol文件:1835667-63-4.mol
-
